Leo R Fitzpatrick Selected Research

olsalazine (Dipentum)

4/2010	Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
4/2008	Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leo R Fitzpatrick Research Topics

Disease

14	Colitis 04/2020 - 05/2002
10	Inflammation (Inflammations) 01/2020 - 05/2007
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2020 - 03/2007
2	Autoimmune Diseases (Autoimmune Disease) 12/2014 - 10/2010
2	Crohn Disease (Crohn's Disease) 04/2010 - 03/2007
2	Disease Progression 04/2010 - 04/2008
2	Ulcerative Colitis 04/2008 - 03/2007
1	Experimental Arthritis 04/2011
1	Arthritis (Polyarthritis) 04/2011
1	Pain (Aches) 01/2011
1	Osteoarthritis 01/2011
1	Fibrosis (Cirrhosis) 03/2010

Drug/Important Bio-Agent (IBA)

6	Dextran SulfateIBA 04/2020 - 07/2006
5	Interleukin-17 (Interleukin 17)IBA 04/2020 - 10/2010
4	CytokinesIBA 04/2020 - 05/2002
4	Sulfonic AcidsIBA 12/2014 - 03/2010
3	sphingosine kinaseIBA 04/2011 - 04/2008
3	3- (4- chlorophenyl)- adamantane- 1- carboxylic acid (pyridin-4-ylmethyl)amideIBA 04/2011 - 04/2010
3	NF-kappa B (NF-kB)IBA 09/2008 - 05/2002
2	AcidsIBA 04/2020 - 01/2020
2	Dextrans (Dextran)FDA Link 01/2020 - 10/2010
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 10/2010
2	Pharmaceutical PreparationsIBA 05/2014 - 10/2010
2	HaptensIBA 09/2012 - 03/2010
2	vidofludimusIBA 09/2012 - 10/2010
2	EnzymesIBA 04/2010 - 04/2008
2	olsalazine (Dipentum)FDA Link 04/2010 - 04/2008
2	Peptides (Polypeptides)IBA 03/2007 - 07/2006
2	Polysaccharides (Glycans)IBA 04/2003 - 05/2002
2	Peptidoglycan (Murein)IBA 04/2003 - 05/2002
1	Transcription Factors (Transcription Factor)IBA 04/2020
1	Orphan Nuclear ReceptorsIBA 04/2020
1	Member 3 Group F Nuclear Receptor Subfamily 1IBA 04/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	bile acid binding proteinsIBA 01/2020
1	naltrindoleIBA 01/2020
1	sodium-bile acid cotransporterIBA 01/2020
1	7-benzylidenenaltrexoneIBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Naltrexone (ReVia)FDA LinkGeneric 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2020
1	FlavonoidsIBA 07/2017
1	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 12/2014
1	TriterpenesIBA 12/2014
1	Interleukin-10 (Interleukin 10)IBA 05/2014
1	melanin-concentrating hormone (melanin concentrating hormone)IBA 05/2014
1	Vancomycin FDA LinkGeneric 10/2012
1	Indomethacin (Indometacin)FDA LinkGeneric 04/2011
1	SphingolipidsIBA 01/2011
1	SphingosineIBA 01/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2010
1	Dihydroorotate DehydrogenaseIBA 10/2010
1	sym-trinitrobenzeneIBA 03/2010
1	Metronidazole (Metric)FDA LinkGeneric 09/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008
1	NF-KappaB Inhibitor alphaIBA 05/2007
1	InterleukinsIBA 05/2007
1	Peroxidase (Myeloperoxidase)IBA 05/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2007
1	GliotoxinIBA 05/2002

Therapy/Procedure

1	Therapeutics 01/2020
1	Oral Administration 10/2010
1	Immunomodulation 09/2008